Back to Search
MIA GORE, MD
MD
Psychiatry Physician
NPI: 1376679704Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
L-228279(MA)234932(MA)
Research & Publications (20)
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.
PMID 19615940·Lancet Oncol·2009
3-trial
Japanese encephalitis virus produces a CD4+ Th2 response and associated immunoprotection in an adoptive-transfer murine model.
PMID 19264621·J Gen Virol·2009
7-preclinical
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.
PMID 18620949·Lancet·2008
3-trial
Transatlantic migration and deep mid-ocean diving by basking shark.
PMID 18511407·Biol Lett·2008
7-preclinical
Establishing the role of cytokine therapy in advanced renal cell carcinoma.
PMID 18279450·BJU Int·2008
6-review
New drug therapies for advanced renal cell carcinoma.
PMID 17187520·Expert Rev Anticancer Ther·2007
6-review
Emerging efficacy endpoints for targeted therapies in advanced renal cell carcinoma.
PMID 16773841·Oncology (Williston Park)·2006
6-review
Intraperitoneal chemotherapy in ovarian cancer remains experimental.
PMID 17008689·J Clin Oncol·2006
8-other
Virtual bronchoscopy for diagnosis of inhalation injury in burnt patients.
PMID 15019127·Burns·2004
8-other
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer.
PMID 12460786·Eur J Cancer·2002
3-trial
Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval.
PMID 12645907·Eur J Cancer·2002
3-trial
A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer.
PMID 11750840·Eur J Cancer·2002
3-trial
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancer.
PMID 11283120·J Clin Oncol·2001
3-trial
Topotecan given as a 21-day infusion in the treatment of advanced ovarian cancer.
PMID 11308251·Br J Cancer·2001
3-trial
Gene expression changes associated with cytotoxicity identified using cDNA arrays.
PMID 11793227·Funct Integr Genomics·2000
8-other
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
PMID 19648919·Nat Genet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MCLEAN HOSPITAL, MS 222, 115 MILL STREET
BELMONT, MA 02478 - Phone
- (617) 855-3070
Quick Facts
- NPI
- 1376679704
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile